Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: A descriptive study using the French Pharmacovigilance database

Fundamental and Clinical Pharmacology

Volumn 28, Issue 2, 2014, Pages 230-235

  Fournier, Jean Pascal ^a,b   Sommet, Agnès ^a,b,c   Durrieu, Geneviève ^a,b,c   Poutrain, Jean Christophe ^a   Lapeyre Mestre, Maryse ^a,b,c   Montastruc, Jean Louis ^a,b,c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b INSERM   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Acute kidney injury; Antihypertensive agents; Drug interactions; Non steroidal anti inflammatory drugs; Pharmacovigilance

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TENOXICAM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; VERY ELDERLY;

ACUTE KIDNEY INJURY; ANTIHYPERTENSIVE AGENTS; DRUG INTERACTIONS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHARMACOVIGILANCE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; DATABASES, PHARMACEUTICAL; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PHARMACOVIGILANCE;

EID: 84895521998     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/fcp.12014     Document Type: Article

References (25)

1. Olyaei A.J., Whelton A., Sturmer T., Porter G.A. Non-steroidal anti-inflammatory drugs. in: de Broe M.E., Porter G.A. (Eds), Clinical Nephrotoxins: Renal injury from drugs and chemicals, 3rd edn, Springer, New York, 2008, pp. 419-457.
2. Kotchen T.A. Chapter 247. Hypertensive vascular disease. in: Longo D.L., Fauci A.S., Kasper D.L., Hauser S.L., Jameson J.L., Loscalzo J. (Eds), Harrison's Principles of Internal Medicine. 18th edn. http://www.accessmedicine.com/content.aspx?aid=9104833a
3. Vidal. Vidal 2011: Le Dictionnaire. 87e ed. Paris: O.V.P. eds. 2011.
4. Prescrire Revue. Éviter les effets indésirables par interactions médicamenteuses - Le Guide Prescrire Édition (2010). Rev. Prescrire. (2009) 29 50-63.
5. Welsch M., Alt M., Richard M.H., Imbs J.L. The French pharmacovigilance system: structure and missions. Presse Med. (2000) 22 102-106.
6. Edwards I.R., Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet (2000) 356 1255-1259.
7. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2012. http://www.whocc.no/atc_ddd_index/ (accessed 16 February 2012)
8. Brown E.G., Wood L., Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. (1999) 20 109-117.
9. Fournier J.P., Lapeyre-Mestre M., Sommet A., Dupouy J., Poutrain J.C., Montastruc J.L. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. PLoS ONE (2012) 7(3) e34187.
10. Lapeyre-Mestre M., Grolleau S., Montastruc J.L. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Fundam. Clin. Pharmacol. (2011). doi: 10.1111/j.1472-8206.2011.00991.x. [Epub ahead of print]
11. Lugardon S., Roussel H., Bourrel R., Sciortino V., Montastruc J.L., Lapeyre-Mestre M. Patterns of non steroidal anti-inflammatory drug use in ambulatory care. Therapy. (2006) 61 109-114.
12. Motola D., Vaccheri A., Silvani M.C. et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur. J. Clin. Pharmacol. (2004) 60 731-738.
13. Fosbøl E.L., Gislason G.H., Jacobsen S. et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol. Drug Saf. (2008) 17 822-833.
14. Rossignol M., Abouelfath A., Lassalle R. et al. The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers. Br. J. Clin. Pharmacol. (2009) 67 118-124.
15. Magro L., Moretti U., Leone R. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. Expert. Opin. Drug. Saf. (2012) 11 83-94.
16. Tavassoli N., Sommet A., Lapeyre-Mestre M., Bagheri H., Montrastruc J.L. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug Saf. (2007) 30 1063-1071.
17. Montastruc F., Sommet A., Bondon-Guitton E. et al. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Eur. J. Clin. Pharmacol. (2012) 68 767-75.
18. Loboz K.K., Shenfield G.M. Drug combinations and impaired renal function - the 'triple whammy'. Br. J. Clin. Pharmacol. (2005) 59 239-243.
19. Conlin P.R., Moore T.J., Swartz S.L. et al. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension (2000) 36 461-465.
20. Fogari R., Zoppi A., Carretta R., Veglio F., Salvetti A. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J. Hypertens. (2002) 20 1007-1014.
21. Pavlicević I., Kuzmanić M., Rumboldt M., Rumboldt Z. Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. Can. J. Clin. Pharmacol. (2008) 15 372-382.
22. Berthet S., Grolleau S., Brefel-Courbon C., Montastruc J.L., Lapeyre-Mestre M. Prevalence of diabetes in France and drug use: study based on the French pharmacovigilance database. Therapie. (2007) 62 483-488.
23. Samson S., Ricordeau P., Pépin S. Hypertension artérielle et facteurs de risque associés: évolutions des traitements entre 2000 et 2006. Points de repère. (2007) 10 1-8.
24. Wagner A., Arveiler D., Ruidavets J.B. État des lieux sur l'hypertension artérielle en France en 2007 : l'étude Mona Lisa. Bulletin Épidemiologique Hebdomadaire. (2008) 16 483-486.
25. Moore N., Noblet C., Kreft-Jais C., Lagier G., Ollagnier M., Imbs J.L. French pharmacovigilance database system: examples of utilisation. Therapie. (1995) 50 557-562.